Table 2.
Variables | Overall survival |
Disease-free survival |
|||||
---|---|---|---|---|---|---|---|
Median OS (IQR) – mths | Univariate P-value | Multivariate P-value | Median OS (IQR) – months | Univariate P-value | Multivariate P-value | ||
Gender | 0.618 | 0.819 | |||||
Vascular resection | 0.674 | 0.678 | |||||
Type of reconstruction | 0.754 | 0.844 | |||||
Tumour size | 0.13 | 0.955 | |||||
Differentiation (Binomial Variable) | Well/Mod | 18.57 (16.65) | 0.031 | 0.161 | 7.42 (6.37) | 0.06 | 0.30 |
Poorly | 13.53 (19.68) | 6.08 (6.08) | |||||
Neural invasion | 0.973 | 0.631 | |||||
Lymphovascular invasion | −ve | 24.26 (26.56) | 0.013 | 0.631 | 8.3 (13.1) | 0.022 | 0.155 |
+ve | 16.37 (15.65) | 7.42 (7.0) | |||||
SMV/PV groove invasion | −ve | 19.57 (27.98) | 0.065 | 0.167 | 0.363 | ||
+ve | 14.47 (18.84) | ||||||
Resection status (R0/R1) | −ve | 22.43 (28.53) | 0.015 | 0.840 | 0.301 | ||
+ve | 16.30 (18.48) | ||||||
Ant. margin status | 0.275 | 0.838 | |||||
Post. margin status | −ve | 18.57 (22.58) | 0.062 | 0.652 | 0.012 | 0.292 | |
+ve | 16.30 (17.78) | ||||||
CBD margin | 0.762 | 0.507 | |||||
+ve lymph node status | −ve | 26.13 (32.26) | 0.005 | 0.048 | 10.34 (17.52) | 0.016 | 0.075 |
+ve | 16.30 (16.27) | 7.10 (6.80) | |||||
Lymph node ratio (LNR)* | 0.018 | 0.016 | 0.287 | ||||
Lymph node burden (LNB)* | 0.0005 | 0.0029 | 0.207 | ||||
Total nodes* | 0.034 | 0.106 | 0.444 |
CBD, common bile duct; LNR, lymph node ratio; LNB, lymph node burden.